Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ANAC > SEC Filings for ANAC > Form 8-K on 8-Apr-2013All Recent SEC Filings

Show all filings for ANACOR PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro



Unregistered Sale of Equity Securities, Other Events, Financial Statem


On April 5, 2013, the Anacor Pharmaceuticals, Inc. (the "Company") entered into a Common Stock Purchase Agreement (the "Purchase Agreement") with the Bill & Melinda Gates Foundation (the "Gates Foundation"), pursuant to which the Company issued 809,061 shares of its unregistered common stock at a purchase price of $6.18 per share for aggregate gross proceeds of approximately $5,000,000. The Purchase Agreement includes representations, warranties and covenants customary for a transaction of this type. No underwriting discounts or commissions were paid in this transaction. Pursuant to the terms of the Purchase Agreement, the Company has agreed to use its commercially reasonable efforts to register the shares of common stock purchased under the Purchase Agreement within 90 days on a Registration Statement on Form S-3. The Purchase Agreement was entered into in connection with the Research Agreement referenced in Item 8.01 of this Current Report.

The securities sold have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements of the Securities Act. The issuance was made in reliance on Rule 506 promulgated under the Securities Act and was made without general solicitation or advertising.

The foregoing description is qualified in its entirety by reference to the Purchase Agreement, a copy of which is attached hereto as Exhibit 4.1, and is incorporate herein by reference.


On April 8, 2013, Anacor Pharmaceuticals, Inc. issued a press release announcing the entry into a Research Agreement with the Gates Foundation. The material terms of the Research Agreement will be described in a subsequent Current Report on Form 8-K.

A copy of such press release is attached as Exhibit 99.1, and is incorporated herein by reference.


(d) Exhibits.

Exhibit Number                               Description
4.1              Common Stock Purchase Agreement between Anacor Pharmaceuticals, Inc.
                 and the Bill & Melinda Gates Foundation, dated as of April 5, 2013.
99.1             Press Release titled "Anacor Pharmaceuticals Receives Significant
                 Investment to Support Neglected Disease Research" dated April 8,

  Add ANAC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ANAC - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.